<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>TWIST1 is a transcription factor that belongs to the family of basic helix-loop-helix proteins involved in epithelial-to-mesenchymal transition and invasion processes </plain></SENT>
<SENT sid="1" pm="."><plain>The TWIST1 protein possesses oncogenic, drug-resistant, angiogenic and invasive properties, and has been related with several human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and other pathologies </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is one of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in which TWIST1 is over-expressed, but its involvement in the clinical outcome of the disease is still unclear </plain></SENT>
<SENT sid="3" pm="."><plain>We tested, by RT-PCR, the expression levels of TWIST1 in <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> paired-sample tissues from a series of 151 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients, in order to investigate its prognostic value as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> marker </plain></SENT>
<SENT sid="4" pm="."><plain>TWIST1 expression was restricted to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues (86.1%) and correlated with lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (LNM) </plain></SENT>
<SENT sid="5" pm="."><plain>Adjusted analysis showed that the expression levels of TWIST1 correlated with overall survival (OS) and disease-free survival (DFS) </plain></SENT>
<SENT sid="6" pm="."><plain>Importantly, TWIST1 expression levels predicted OS specifically at stages I and II </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, patients with stage II <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and high TWIST1 levels showed even shorter survival than patients with stage III <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>These results suggest that TWIST1 expression levels could be a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> indicator in stage II patients and help select patients at greater risk of poor prognosis who might benefit from adjuvant chemotherapy </plain></SENT>
</text></document>